Search
Anixa Biosciences Inc
ANIXAdd to Watchlist
2.620USD
-0.120-4.38%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
89.14MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-25The current earnings forecast score of Anixa Biosciences Inc is 8.00, ranking 165 out of 387 in the Biotechnology & Medical Research industry. The average price target is 9.50, with a high of 14.00 and a low of 7.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
10.000
Target Price
+262.32%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Anixa Biosciences Inc
ANIX
3
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Anixa Biosciences Inc's price target?
Analysts forecast that Anixa Biosciences Inc's price target is USD 9.50, with the highest forecast at USD 14.00 and the lowest forecast at USD 7.00.
How have Anixa Biosciences IncANIX's recent earnings per share performed?
The market expectation was USD -0.07, while Anixa Biosciences IncANIX's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for Anixa Biosciences Inc?
Based on the ratings of Anixa Biosciences Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
